Louis G Lange insider trades
Open-market stock purchases and sales by Louis G Lange, Unknown at NewAmsterdam Pharma Co NV, from SEC Form 4 filings since May 27, 2010.
Track record: 33% of 3 scored buys are up 5% or more since purchase, averaging -30%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 11, 2026 | NAMS NewAmsterdam Pharma Co NV | Sold | $13.9K |
| Mar 11, 2026 | NAMS NewAmsterdam Pharma Co NV | Sold | $1.3M |
| Mar 9, 2026 | NAMS NewAmsterdam Pharma Co NV | Bought (not open market) | — |
| Mar 6, 2026 | NAMS NewAmsterdam Pharma Co NV | Sold | $829K |
| Jan 7, 2026 | NAMS NewAmsterdam Pharma Co NV | Bought (not open market) | — |
| Jan 7, 2026 | NAMS NewAmsterdam Pharma Co NV | Bought (not open market) | — |
Companies traded
- NAMS NewAmsterdam Pharma Co NV: 1 buy, 3 sales, last Mar 11, 2026
- BOLD Audentes Therapeutics, Inc: 59 sales, last Jan 15, 2020
- CBAY CymaBay Therapeutics, Inc: other filings, last Jun 24, 2015
- NONE CymaBay Therapeutics, Inc: other filings, last Jan 6, 2014
- ESPR Esperion Therapeutics, Inc: 2 buys, last Jul 1, 2013
- MAXY Maxygen Inc: other filings, last Jun 6, 2012